DNA glycosylase (NEIL3) overexpression associated with low tumor immune infiltration and poor overall patient survival in endometrial cancer
Abstract Endometrial cancer (EC) is the most common gynecological malignancy. Although prognosis is favorable for patients with an early-stage disease, those with recurrent or more advanced disease have low response rates to chemotherapy and poor clinical outcomes. Previously, we have shown that DNA...
Saved in:
| Main Authors: | Cristofer Barry, Aashirwad Shahi, Dawit Kidane |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-00393-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification and validation of NEIL2 as a prognostic biomarker and potential therapeutic target in cervical cancer
by: Yan Li, et al.
Published: (2025-07-01) -
Microsatellite instability as a reliable marker of coexisting endometrial cancer in atypical endometrial hyperplasia
by: А. E. Protasova, et al.
Published: (2024-07-01) -
PHENOTYPIC FEATURES OF ENDOMETRIAL CANCER AND MSI IN COLON AND BLOOD SERUM
by: S. M. Kartashov, et al.
Published: (2014-04-01) -
Analysis of prognostic factors for endometrial cancer, taking into account the insulin-like growth factor IGF-1,2, its activation pathway and related genes in the context of the involvement of Forkhead box and FGFR2 proteins in the treatment of endometrial cancer
by: Olga Adamczyk-Gruszka, et al.
Published: (2024-11-01) -
CCDC138 overexpression predicts poor prognosis and highlights ciliopathy-linked mechanisms in uterine corpus endometrial carcinoma
by: Aiping Wang, et al.
Published: (2025-08-01)